INCONTINENCE - PowerPoint PPT Presentation

1 / 19
About This Presentation
Title:

INCONTINENCE

Description:

Involuntary loss of urine or stool in sufficient amount or frequency to ... of urine to continuous urinary incontinence with concomitant faecal incontinence. ... – PowerPoint PPT presentation

Number of Views:160
Avg rating:3.0/5.0
Slides: 20
Provided by: guil7
Category:

less

Transcript and Presenter's Notes

Title: INCONTINENCE


1
INCONTINENCE
  • For Aged Care Staff

2
INCONTINENCE
  • Involuntary loss of urine or stool in sufficient
    amount or frequency to constitute a social and or
    health problem.
  • A heterogeneous condition that ranges in severity
    from dribbling small amounts of urine to
    continuous urinary incontinence with concomitant
    faecal incontinence.
  • Prevalence increases with age, but it is not part
    of the normal aging

3
The statistics
  • Incontinence occurs in
  • approximately 50 of nursing home residents
  • 25-30 of community dwelling older women
  • 10-15 of community dwelling older men.
  • 545,000 or 2.8 of the Australian adult
    population have severe incontinence.
  • 128,800 of the total live in care accomodation
    requiring assistance including frequent leakage
    events and assistance due to mobility limitation

4
TYPES OF INCONTINENCE
  • Urge-common in elderly
  • Stress
  • Overflow
  • Functional

5
MANAGEMENT
  • Physical examination form local problems, e.g.
    prostatic enlargement in men, gynaecological
    disorders in women, and for central problems, eg
    neurological disorders or dementia
  • Urine analysis, e.g. glycosuria and culture for
    UTI
  • Treatment of contributing causes, e.g.
    constipation, drug therapy, other co-existing
    disease

6
MANAGEMENT (cont)
  • Urge Incontinence
  • bladder training
  • anti-muscarinics, eg oxybutynin, fenosteride
  • Stress incontinence
  • pelvic floor exercises
  • Overflow
  • removal of obstruction
  • Functional
  • improve facilities
  • regular urine voiding
  • absorbent padding.

7
MEDICATIONS THAT CAN CONTRIBUTE TO INCONTINENCE
  • Medications can be a common cause of incontinence
  • Alpha-blockers (eg prazosin)
  • Diuretics
  • Sedatives
  • Calcium channel blockers
  • Sympathomimetic decongestants (eg pseudoephedrine)
  • Anticholinergics (doxepin, hyoscine, ipratropium,
    benztropine, chlorpromazine, imipramine,
    amitriptyline)

8
URGE INCONTINENCE
  • Urgency incontinence due to increased activity of
    the detrusor smooth muscle may be worsened by
  • poor mobility, resulting in patients not reaching
    the toilet in time
  • by urinary tract infection.
  • For symptomatic control, use
  • oxybutynin

9
OXYBUTYNIN(Ditropan)
  • DOSE
  • Elderly, start with 2.5 mg at night and increase
    slowly if necessary. (AMH 2008)
  • 5 mg orally, 2 or 3 times daily (decrease dose in
    the elderly or debilitated to 2.5 mg twice daily,
    maximum (eTG)
  • ADVERSE EFFECTS cognitive dysfunction
  • confusion, hallucinations, anxiety, paranoia

10
SOLIFENACIN (Vesicare)
  • DOSE
  • Adult, initially, 5 mg once daily if necessary,
    increase dose to 10 mg once daily.
  • Do not exceed 5 mg daily in people with moderate
    hepatic impairment, creatinine clearance
    lt30 ml/minute or taking potent CYP3A4 inhibitors
    (eg itraconazole, ketoconazole, ritonavir).
  • Counselling
  • Swallow tablet whole do not crush or chew
  • Adverse Effects anticholinergic eg dry mouth,
    urinary retention, constipation

11
STRESS INCONTINENCE
  • May respond to
  • prazosin 0.5 mg orally, twice daily, increasing
    to 2 mg, twice daily, if tolerated
  •  OR
  •  
  • amitriptyline 25 mg orally, at night, increasing
    to 100 mg daily, if tolerated

12
PRAZOSIN (Minipress, Pressin)
  • Relax smooth muscle in the bladder neck and
    prostate, decreasing resistance to urinary flow.
  • DOSE
  • 0.5 mg twice daily for 37 days, then increase
    according to clinical response up to 2 mg twice
    daily
  • dose must be adjusted according to individual
    response
  • if treatment is interrupted for several days,
    restart and titrate dosage as if starting for the
    first time
  • stop if there is no benefit after 46 weeks of
    maximal treatment
  • Adverse Effects
  • first dose hypotension is common with the
    selective alpha-blockers it is most serious in
    the elderly and in patients with fluid depletion
    or who are taking diuretics

13
TAMSULOSIN (Flomaxtra)
  • Relax smooth muscle in the bladder neck and
    prostate, decreasing resistance to urinary flow.
  • DOSE 400 mg once daily, in the morning.
  • Counselling Swallow whole, with or after food
  • Adverse Effects postural hypotension, dizziness,
    priapism,

14
OTHER FORMS OF INCONTINENCE
  • In terminal illness (eg due to complete sphincter
    dysfunction from spinal cord compression) can be
    managed with absorbent padding or an indwelling
    catheter.
  • Involvement of a urologist or continence clinical
    nurse consultant can be helpful

15
BENIGN PROSTATIC HYPERTROPHY
  • BPH is the most common prostatic disorder can
    cause urinary obstruction with symptoms such as
    hesitancy, dribbling after urination, nocturia,
    frequency and urgency and may culminate in
    urinary retention.
  • Neither the presence or absence of residual urine
    nor the size of the prostate are related to
    symptom severity, degree of obstruction or
    treatment outcome.

16
BPH Before starting treatment
  • Exclude prostate cancer, UTI and renal failure.
  • Differentiate nocturia from polyuria (use a fluid
    balance diary). Heart failure may cause nocturia.
  • Consider using a scoring system to assess
    symptoms and monitor progress, eg International
    Prostate Symptom Score,
  • Mild symptoms, not causing undue discomfort,
    where surgery is not indicated, do not need
    active treatment, but watchful waiting with
    periodic reassessment.

17
FINASTERIDE (PROSCAR)
  • Reduces prostate size but appears to be effective
    only if the prostate is significantly enlarged
    (gt40 cm3). Full clinical response may take
    6 months or more. Generally well tolerated,
    although may cause sexual dysfunction. Less cost
    effective than selective alpha-blockers.
  • Drug Handling Women who are or may become
    pregnant should not handle broken or crushed
    tablets without gloves (ADEC category X)

18
URINARY TRACT INFECTION
  • Management of UTI in the elderly can be
    difficult. Sometimes over prescribing of
    antibiotics, with associated risk of adverse
    effects and development of resistance.
  • Key messages include
  • Asymptomatic bacteriuria is common in the
    elderly.
  • Cloudy or malodorous urine in a patient without
    symptoms or signs does not require investigation
    or treatment.
  • Elderly patients with signs and symptoms of
    sepsis require urgent treatment.

19
REFERENCES
  • http//www.continence.org.au/site/index.cfm
  • International Prostate Score www.usrf.org/question
    naires/AUA_SymptomScore.html
  • Therapeutic Guidelines
  • Australian Medicines Handbook
  • eMIMS
Write a Comment
User Comments (0)
About PowerShow.com